- Report
- March 2026
- 250 Pages
Global
From €3986EUR$4,490USD£3,409GBP
- Report
- September 2025
- 321 Pages
Global
From €1952EUR$2,199USD£1,670GBP
- Report
- August 2026
- 150 Pages
Global
From €2486EUR$2,800USD£2,126GBP
- Report
- May 2026
- 1200 Pages
Global
From €4438EUR$5,000USD£3,797GBP
- Report
- May 2026
- 180 Pages
Global
From €2308EUR$2,600USD£1,974GBP
- Report
- January 2026
- 270 Pages
Global
From €2486EUR$2,800USD£2,126GBP
- Report
- January 2026
- 240 Pages
Global
From €2219EUR$2,500USD£1,898GBP
- Report
- September 2025
- 120 Pages
Global
From €2486EUR$2,800USD£2,126GBP
- Report
- September 2025
Global
From €2663EUR$3,000USD£2,278GBP
- Report
- April 2026
- 621 Pages
Global
From €6347EUR$7,150USD£5,429GBP
- Report
- January 2026
- 409 Pages
Global
From €4394EUR$4,950USD£3,759GBP
- Report
- February 2026
- 200 Pages
Global
From €2654EUR$2,990USD£2,270GBP
- Report
- May 2026
- 150 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- April 2026
- 120 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- October 2025
- 150 Pages
Global
From €5282EUR$5,950USD£4,518GBP
- Report
- August 2026
- 191 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 188 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 184 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 188 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP
- Report
- August 2026
- 192 Pages
Global
From €3147EUR$3,545USD£2,692GBP
€3497EUR$3,939USD£2,991GBP

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more